Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.50    0.00 (0.00%)
Bid:
18.00
Ask:
19.00
Spread: 1.00 (5.556%)
Market Cap: £16.76m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

LTIP Awards

17 May 2016 15:56

RNS Number : 5154Y
The Mission Marketing Group PLC
17 May 2016
 

 

 

The Mission Marketing Group plc

 

LTIP awards

 

 

The Mission Marketing Group plc ("the Company" or 'the missiontm', AIM: TMMG), the marketing communications and advertising group, announces the following details of awards of nil-cost options under the TMMG Long Term Incentive Plan (the "LTIP").

 

The Remuneration Committee of the TMMG Board ("RemCo") has today approved the grant of 1,040,000 new LTIP options to certain Directors and employees, representing 1.2% of the Company's current non-diluted issued share capital. The vesting of these LTIP options is dependent upon achieving levels of profit growth over the three year period of the options, with a sliding scale of vesting dependent upon the level of growth. Maximum vesting will be triggered by compound profit growth of 10% pa or more.

 

Separately, RemCo has today judged that the profit performance in relation to LTIP options granted in 2013, which were dependent upon profits over the three year period ended on 31 December 2015, was insufficient for those awards to vest when they reach maturity in July 2016. As a consequence, all of the LTIP options granted in 2013 have lapsed.

 

The following table sets out a summary of the LTIPs awarded to Directors and their resultant holdings:

 

 

Existing LTIP

options

New LTIP

options

Lapsed

options

Total LTIP

options

 

 

 

 

 

Dylan Bogg

99,500

35,000

(30,000)

104,500

James Clifton

139,215

35,000

(56,000)

118,215

Robert Day

216,667

50,000

(110,000)

156,667

Peter Fitzwilliam

100,000

25,000

(50,000)

75,000

Chris Goodwin

72,500

25,000

(35,000)

62,500

Giles Lee

222,000

50,000

(70,000)

202,000

David Morgan

100,000

20,000

(50,000)

70,000

Chris Morris

100,000

20,000

(50,000)

70,000

Sue Mullen

42,500

20,000

(22,500)

40,000

Fiona Shepherd

110,000

50,000

(50,000)

110,000

 

The resulting total number of LTIP options in issue following today's grants and lapsing of the 2013 LTIPs is 2,770,000, representing 3.3% of the Company's issued share capital.

 

The vesting of LTIP options may be satisfied by ordinary shares held by the The Mission Marketing Group Employee Benefit Trust ("EBT") and/or through the issue of new shares. As previously notified, the Directors would prefer to satisfy LTIP commitments by transferring shares held by the EBT rather than diluting all shareholders through the issue of new ordinary shares. The Trustees of the EBT make periodic share purchases as they deem appropriate and, as at the current date, hold 1,418,206 ordinary shares, representing approximately 1.7% of the issued share capital of the Company.

 

Enquiries:

  Peter Fitzwilliam, Finance Director

The Mission Marketing Group plc

 

020 7462 1415

 

Geoff Nash/James Thompson (Corporate Finance)

Stephen Norcross (Corporate Broking)

 

finnCap Limited

020 7220 0500

 

the missiontm is a network of entrepreneurial marketing communications Agencies employing over 950 people in the UK, Asia and San Francisco. The Group comprises a complementary mix of integrated generalists, specialists in specific marketing/communications activities and specialists in particular market sectors, all providing award-winning solutions to national and international Clients.

 

www.themission.co.uk

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGGUWAAUPQGCM
Date   Source Headline
27th Sep 20227:00 amRNSCHANGES TO THE BOARD
26th Aug 202210:27 amRNSHolding(s) in Company
18th Aug 202210:30 amRNSEBT Share Dealing
17th Aug 20228:45 amRNSEBT Share Dealing
15th Aug 20222:29 pmRNSEBT Share Dealing
12th Aug 20227:00 amRNSEBT Share Dealing
10th Aug 20229:00 amRNSEBT Share Dealing
8th Aug 20228:51 amRNSEBT Share Dealing
5th Aug 20229:36 amRNSEBT Share Dealing
3rd Aug 20227:00 amRNSEBT Share Dealing
25th Jul 20223:47 pmRNSEBT Share Dealing
20th Jul 20228:22 amRNSEBT Share Dealing
19th Jul 20227:00 amRNSEBT Share Purchase
15th Jul 202210:22 amRNSEBT Share Purchase
14th Jul 20229:34 amRNSEBT Share Dealing
13th Jul 20227:00 amRNSTrading Update
8th Jul 20229:02 amRNSEBT Share Dealing
5th Jul 20223:44 pmRNSEBT Share Dealing
30th Jun 20228:55 amRNSEBT Share Dealing
29th Jun 202211:54 amRNSEBT Share Dealing
21st Jun 20222:35 pmRNSResult of AGM
17th Jun 20227:00 amRNSEBT Share Dealing
16th Jun 20227:00 amRNSEBT Share Dealing
15th Jun 20227:00 amRNSEBT Share Dealing
14th Jun 20227:00 amRNSEBT Share Dealing
13th Jun 20227:00 amRNSEBT Share Dealing
10th Jun 20227:00 amRNSEBT Share Dealing
9th Jun 20227:00 amRNSEBT Share Dealing
1st Jun 20228:46 amRNSEBT Share Dealing
31st May 20227:00 amRNSEBT Share Dealing
24th May 202210:48 amRNSEBT Share Dealing
23rd May 20227:00 amRNSEBT Share Dealing
20th May 20227:00 amRNSEBT Share Dealing
19th May 20227:00 amRNSEBT Share Dealing
18th May 20227:00 amRNSEBT Share Dealing
17th May 20227:00 amRNSEBT Share Dealing
16th May 20227:00 amRNSEBT Share Dealing
12th May 20222:36 pmRNSEBT Share Dealing
20th Apr 20229:04 amRNSDirector Dealing
30th Mar 20227:00 amRNSDividend Timetable
29th Mar 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
28th Feb 20227:00 amRNSACQUISITION OF LIVITY
19th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
10th Jan 20221:54 pmRNSHolding(s) in Company
5th Jan 202210:07 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:16 amRNSHolding(s) in Company
25th Oct 20214:49 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSAcquisition of Soul and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.